These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8691095)

  • 21. Duchenne muscular dystrophy.
    Chamberlain JS
    Curr Opin Genet Dev; 1991 Jun; 1(1):11-4. PubMed ID: 1840869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic removal of a therapeutic mini-dystrophin gene from adult mice elicits a Duchenne muscular dystrophy-like phenotype.
    Wasala NB; Lai Y; Shin JH; Zhao J; Yue Y; Duan D
    Hum Mol Genet; 2016 Jul; 25(13):2633-2644. PubMed ID: 27106099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Challenges for gene therapy for muscular dystrophy.
    Mendell JR; Clark KR
    Curr Neurol Neurosci Rep; 2006 Jan; 6(1):47-56. PubMed ID: 16469271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Full-length dystrophin gene transfer to the mdx mouse in utero.
    Reay DP; Bilbao R; Koppanati BM; Cai L; O'Day TL; Jiang Z; Zheng H; Watchko JF; Clemens PR
    Gene Ther; 2008 Apr; 15(7):531-6. PubMed ID: 18273052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenoviral vectors for gene transfer of full-length human dystrophin cDNAs.
    Murphy S; Turner G; Piper T; Roberts B; Wadworth S; Smith AE; Wells DJ; Dickson G
    Biochem Soc Trans; 1996 May; 24(2):277S. PubMed ID: 8736935
    [No Abstract]   [Full Text] [Related]  

  • 26. Human dystrophin gene transfer: genetic correction of dystrophin deficiency.
    Dickson G; Dunckley M
    Mol Cell Biol Hum Dis Ser; 1993; 3():283-302. PubMed ID: 8111543
    [No Abstract]   [Full Text] [Related]  

  • 27. CTLA4Ig delivered by high-capacity adenoviral vector induces stable expression of dystrophin in mdx mouse muscle.
    Jiang Z; Schiedner G; Gilchrist SC; Kochanek S; Clemens PR
    Gene Ther; 2004 Oct; 11(19):1453-61. PubMed ID: 15269713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular approaches to therapy for Duchenne and limb-girdle muscular dystrophy.
    Stedman HH
    Curr Opin Mol Ther; 2001 Aug; 3(4):350-6. PubMed ID: 11525558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fails to prevent dystrophy.
    Cox GA; Sunada Y; Campbell KP; Chamberlain JS
    Nat Genet; 1994 Dec; 8(4):333-9. PubMed ID: 7894482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy.
    Ahmad A; Brinson M; Hodges BL; Chamberlain JS; Amalfitano A
    Hum Mol Genet; 2000 Oct; 9(17):2507-15. PubMed ID: 11030755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The physiological evaluation of gene therapies of dystrophin-deficient muscles.
    Gillis JM; Deconinck N
    Adv Exp Med Biol; 1998; 453():411-6; discussion 417. PubMed ID: 9889852
    [No Abstract]   [Full Text] [Related]  

  • 32. The IVth workshop on Duchenne muscular dystrophy gene therapy.
    Schwartz K; Leterrier F
    J Gene Med; 1999; 1(6):444-8. PubMed ID: 10753071
    [No Abstract]   [Full Text] [Related]  

  • 33. [Advances in genome editing technologies for treating muscular dystrophy.].
    Makita Y; Hozumi H; Hotta A
    Clin Calcium; 2017; 27(3):391-399. PubMed ID: 28232654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene therapy for muscular dystrophies: current status and future prospects.
    Takeda S; Miyagoe-Suzuki Y
    BioDrugs; 2001; 15(10):635-44. PubMed ID: 11604045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Updates in muscular dystrophies].
    Erazo-Torricelli R
    Rev Neurol; 2004 Nov 1-15; 39(9):860-71. PubMed ID: 15543503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene therapy in large animal models of muscular dystrophy.
    Wang Z; Chamberlain JS; Tapscott SJ; Storb R
    ILAR J; 2009; 50(2):187-98. PubMed ID: 19293461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Introduction of rod-deleted dystrophin cDNA, delta DysM3, into mdx skeletal muscle using adenovirus vector].
    Yuasa K; Ishii A; Miyagoe Y; Takeda S
    Nihon Rinsho; 1997 Dec; 55(12):3148-53. PubMed ID: 9436426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Duchenne muscular dystrophy].
    Ishiura S; Sugita H
    No To Shinkei; 1991 May; 43(5):405-9. PubMed ID: 1910927
    [No Abstract]   [Full Text] [Related]  

  • 39. Gene delivery goes global.
    Thomas CE
    Nat Med; 2004 Aug; 10(8):782-3. PubMed ID: 15286775
    [No Abstract]   [Full Text] [Related]  

  • 40. Patient page. Gene therapy and muscular dystrophies.
    Karceski S
    Neurology; 2008 Jul; 71(4):e6-8. PubMed ID: 18645160
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.